Table 2.
Uses of immunosuppressive agents in ophthalmologic conditions.
| Drug | Diagnosis |
|---|---|
| Antimetabolites | |
| Methotrexate | Chronic non-infectious uveitis, sarcoidosis, and non-infectious ocular inflammation |
| Azathioprine | Chronic uveitis, Behcet's disease, choroidal neovascularization, OCP, retinal vasculitis, serpiginous choroiditis, and neuroretinitis |
| Mycophenolate mofetil | Chronic uveitis, non-infectious ocular inflammation, intermediate and posterior uveitis, refractory uveitis, and scleritis |
| Leflunomide | Sarcoidosis uveitis |
|
| |
| Alkylating agents | |
| Cyclophosphamide | Refractory uveitis, peripheral uveitis, Wegener, OCP, scleritis, Behçet's disease, non-infectious ocular inflammation, and optic neuropathy (SLE) |
| Chlorambucil | Serpiginous choroiditis, severe chronic uveitis, uveitis, and Behçet's disease |
|
| |
| T-cell inhibitors/calcineurin inhibitors | |
| Cyclosporine | Serpiginous choroidopathy, Behçet's disease, endogenous uveitis, chronic idiopathic uveitis, scleritis, rheumatoid arthritis, and non-infectious uveitis |
| Tacrolimus | Refractory uveitis (limited experience) |
| Rapamycin | Refractory uveitis (limited experience) |
|
| |
| Biologic agents | |
| Etanercept | Juvenile idiopathic arthritis, non-infectious uveitis, and ocular inflammatory disease |
| Infliximab | Refractory uveitis, childhood uveitis, Behcet's disease, and refractory uveitis |
| Adalimumab | Refractory uveitis, ankylosing spondylitis, and juvenile idiopathic arthritis |
| Daclizumab | Juvenile idiopathic arthritis, recalcitrant ocular inflammation, and birdshot retinochoroidopathy |
| Rituximab | Primary Sjogren syndrome, thyroid eye disease, and Wegener |
| Tocilizumab | Refractory uveitis (limited experience) |
|
| |
| Other | |
| Interferons | Behcet's disease, non-infectious uveitis |